Collectrin and ACE2 in renal and intestinal amino acid transport

Channels

Volumn 5, Issue 5, 2011, Pages

  Singer, Dustin ^a   Camargo, Simone M R ^b  

^a AGROPARISTECH   (France)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

ACE2; Amino acid transporters; Hartnup disorder; Kidney; Renin angiotensin system; SLC6; Small intestine; Tmem27

Indexed keywords

AMINO ACID TRANSPORTER; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; ANGIOTENSIN II; CD98 ANTIGEN; GLYCINE TRANSPORTER 1; GLYCINE TRANSPORTER 2; MEMBRANE PROTEIN; NEUROTRANSMITTER TRANSPORTER; PEPTIDE HYDROLASE; SOLUTE CARRIER FAMILY 6; TMEM 27; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; CATALYSIS; GENE MUTATION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SODIUM TRANSPORT; TISSUE DISTRIBUTION;

EID: 80052610494     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.5.5.16470     Document Type: Review

References (101)

1. - neurotransmitter transporters. J Neurochem 1998; 71:1785-803.
2. Chen NH, Reith ME, Quick MW. Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch 2004; 447:519-31. (Pubitemid 38241438)
3. Broer S. The SLC6 orphans are forming a family of amino acid transporters. Neurochem Int 2006; 48:559-67.
4. Doyle FA, McGivan JD. The bovine renal epithelial cell line NBL-1 expresses a broad specificity Na(+)- dependent neutral amino acid transport system (System Bo) similar to that in bovine renal brush border membrane vesicles. Biochim Biophys Acta 1992; 1104:55-62.
5. Doyle FA, McGivan JD. Reconstitution and identification of the major Na+-dependent neutral amino acid-transport protein from bovine renal brush-border membrane vesicles. Biochem J 1992; 281:95-102.
6. 0, a neutral amino acid transporter related to Hartnup disorder. J Biol Chem 2004; 279:24467-76.
7. 0AT1 sodium-dependent neutral amino acid transporter. Pflugers Arch 2005; 451:338-48.
8. 0AT1 (slc6a19). Biochem J 2005; 389:745-51.
9. Kowalczuk S, Broer A, Tietze N, Vanslambrouck JM, Rasko JE, Broer S. A protein complex in the brush-border membrane explains a Hartnup disorder allele. Faseb J 2008; 22:2880-7.
10. 0AT-cluster and their tissue distribution in Mus musculus. Am J Physiol Renal Physiol 2006; 290:376-83.
11. Camargo SM, Singer D, Makrides V, Huggel K, Pos KM, Wagner CA, et al. Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations. Gastroenterology 2009; 136:872-82.
12. Danilczyk U, Sarao R, Remy C, Benabbas C, Stange G, Richter A, et al. Essential role for collectrin in renal amino acid transport. Nature 2006; 444:1088-91. (Pubitemid 46018530)
13. Malakauskas SM, Quan H, Fields TA, McCall SJ, Yu MJ, Kourany WM, et al. Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin. Am J Physiol Renal Physiol 2007; 292:533-44.
14. + neutral amino acid cotransporter (Slc6a19) deficient mouse. J Biol Chem 2011; In press.
15. 0AT2). Biochem J 2006; 393:421-30.
16. Takanaga H, Mackenzie B, Peng JB, Hediger MA. Characterization of a branched-chain amino-acid transporter SBAT1 (SLC6A15) that is expressed in human brain. Biochem Biophys Res Commun 2005; 337:892-900. (Pubitemid 41446998)
17. Drgonova J, Liu QR, Hall FS, Krieger RM, Uhl GR. Deletion of v7-3 (SLC6A15) transporter allows assessment of its roles in synaptosomal proline uptake, leucine uptake and behaviors. Brain Res 2007; 1183:10-20. (Pubitemid 350088688)
18. 0AT3. J Biol Chem 2009; 284:19953-60.
19. Vanslambrouck JM, Broer A, Thavyogarajah T, Holst J, Bailey CG, Broer S, et al. Renal imino acid and glycine transport system ontogeny and involvement in developmental iminoglycinuria. Biochem J 2010; 428:397-407.
20. Parks LD, Barfuss DW. Transepithelial transport and metabolism of glycine in S1, S2, and S3 cell types of the rabbit proximal tubule. Am J Physiol Renal Physiol 2002; 283:1208-15.
21. Quan H, Athirakul K, Wetsel WC, Torres GE, Stevens R, Chen YT, et al. Hypertension and impaired glycine handling in mice lacking the orphan transporter XT2. Mol Cell Biol 2004; 24:4166-73. (Pubitemid 41070990)
22. Eslami B, Kinboshi M, Inoue S, Harada K, Inoue K, Koizumi A. A nonsense polymorphism (Y319X) of the solute carrier family 6 member 18 (SLC6A18) gene is not associated with hypertension and blood pressure in Japanese. Tohoku J Exp Med 2006; 208:25-31. (Pubitemid 41800185)
23. Matsumoto K, Shimodaira M, Nakagawa T, Nakayama T, Nakazato T, Izumi Y, et al. Association study: SLC6A18 gene and myocardial infarction. Clin Biochem 2011.
24. Howard A, Goodlad RA, Walters JR, Ford D, Hirst BH. Increased expression of specific intestinal amino acid and peptide transporter mRNA in rats fed by TPN is reversed by GLP-2. J Nutr 2004; 134:2957-64. (Pubitemid 39470069)
25. Kim KM, Kingsmore SF, Han H, Yang-Feng TL, Godinot N, Seldin MF, et al. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes. Mol Pharmacol 1994; 45:608-17. (Pubitemid 24139187)
26. Poyatos I, Ruberti F, Martinez-Maza R, Gimenez C, Dotti CG, Zafra F. Polarized distribution of glycine transporter isoforms in epithelial and neuronal cells. Mol Cell Neurosci 2000; 15:99-111. (Pubitemid 30090384)
27. Gomeza J, Hulsmann S, Ohno K, Eulenburg V, Szoke K, Richter D, et al. Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron 2003; 40:785-96. (Pubitemid 37431038)
28. Martinez-Maza R, Poyatos I, Lopez-Corcuera B, E Nu, Gimenez C, Zafra F, et al. The role of N-glycosylation in transport to the plasma membrane and sorting of the neuronal glycine transporter GLYT2. J Biol Chem 2001; 276:2168-73. (Pubitemid 32109699)
29. Gomeza J, Ohno K, Hulsmann S, Armsen W, Eulenburg V, Richter DW, et al. Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 2003; 40:797-806. (Pubitemid 37431039)
30. --dependent transporter family: chromosomal localization and distribution in GABAergic and glutamatergic neurons in the rat brain. J Neurochem 1994; 62:445-55.
31. Parra LA, Baust T, El Mestikawy S, Quiroz M, Hoffman B, Haflett JM, et al. The orphan transporter Rxt1/NTT4 (SLC6A17) functions as a synaptic vesicle amino acid transporter selective for proline, glycine, leucine and alanine. Mol Pharmacol 2008; 74:1521-32.
32. +-coupled neutral amino acid transport. J Biol Chem 2009; 284:8439-48.
33. Cheval L, Pierrat F, Dossat C, Genete M, Imbert-Teboul M, Duong Van Huyen JP, et al. Atlas of gene expression in the mouse kidney: new features of glomerular parietal cells. Physiol Genomics 2011; 43:161-73.
34. 0+. J Biol Chem 1999; 274:23740-5.
35. 0+ amino acid transporter related to amino acid absorption in colon. Am J Physiol Gastrointest Liver Physiol 2001; 281:365-70.
36. --dependent proline transporter. Biochem J 2005; 386:417-22.
37. Takanaga H, Mackenzie B, Suzuki Y, Hediger MA. Identification of mammalian proline transporter SIT1 (SLC6A20) with characteristics of classical system imino. J Biol Chem 2005; 280:8974-84. (Pubitemid 40409589)
38. + and pH dependence of proline and beta-alanine absorption in rat small intestine. Acta Physiol (Oxf) 2006; 186:271-8.
39. Boll M, Foltz M, Rubio-Aliaga I, Kottra G, Daniel H. Functional characterization of two novel mammalian electrogenic proton-dependent amino acid cotransporters. J Biol Chem 2002; 277:22966-73. (Pubitemid 34967281)
40. +/amino acid transporter rat PAT2 (Slc36a2). Br J Pharmacol 2005; 144:28-41.
41. Shafqat S, Velaz-Faircloth M, Henzi VA, Whitney KD, Yang-Feng TL, Seldin MF, et al. Human brain-specific L-proline transporter: molecular cloning, functional expression and chromosomal localization of the gene in human and mouse genomes. Mol Pharmacol 1995; 48:219-29.
42. Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y. CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch 2004; 447:532-42. (Pubitemid 38258215)
43. Pfeiffer R, Loffing J, Rossier G, Bauch C, Meier C, Eggermann T, et al. Luminal heterodimeric amino acid transporter defective in cystinuria. Mol Biol Cell 1999; 10:4135-47.
44. Bartoccioni P, Rius M, Zorzano A, Palacin M, Chillaron J. Distinct classes of trafficking rBAT mutants cause the type I cystinuria phenotype. Hum Mol Genet 2008; 17:1845-54. (Pubitemid 351791512)
45. 0,+ AT heterodimeric amino acid transporter. Biochem J 2009; 417:441-8.
46. Chillaron J, Font-Llitjos M, Fort J, Zorzano A, Goldfarb DS, Nunes V, et al. Pathophysiology and treatment of cystinuria. Nat Rev Nephrol 2010; 6:424-34.
47. Ruggiero AM, Liu Y, Vidensky S, Maier S, Jung E, Farhan H, et al. The endoplasmic reticulum exit of glutamate transporter is regulated by the inducible mammalian Yip6b/GTRAP3-18 protein. J Biol Chem 2008; 283:6175-83.
48. Butchbach ME, Lai L, Lin CL. Molecular cloning, gene structure, expression profile and functional characterization of the mouse glutamate transporter (EAAT3) interacting protein GTRAP3-18. Gene 2002; 292:81-90. (Pubitemid 34761991)
49. Ramadan T, Camargo SM, Herzog B, Bordin M, Pos KM, Verrey F. Recycling of aromatic amino acids via TAT1 allows efflux of neutral amino acids via LAT2- 4F2hc exchanger. Pflugers Arch 2007; 454:507-16. (Pubitemid 46742427)
50. Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009; 136:521-34.
51. Corvol P, Michaud A, Soubrier F, Williams TA. Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme. J Hypertens Suppl 1995; 13:3-10.
52. Skeggs LT, Dorer FE, Levine M, Lentz KE, Kahn JR. The biochemistry of the renin-angiotensin system. Advances in experimental medicine and biology 1980; 130:1-27.
53. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52:415-72.
54. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977; 57:313-70. (Pubitemid 8097628)
55. Johren O, Bruggemann N, Dominiak P. Orexins (hypocretins) and adrenal function. Hormone and metabolic research = Hormon-und Stoffwechselforschung = Hormones et metabolisme 2004; 36:370-5. (Pubitemid 38932092)
56. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275:33238-43.
57. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87:1-9.
58. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277:14838-43. (Pubitemid 34952556)
59. Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, et al. The emerging role of ACE2 in physiology and disease. J Pathol 2007; 212:1-11. (Pubitemid 46746284)
60. Lambert MH, Blackburn RK, Seaton TD, Kassel DB, Kinder DS, Leesnitzer MA, et al. Substrate specificity and novel selective inhibitors of TNFalpha converting enzyme (TACE) from two-dimensional substrate mapping. Comb Chem High Throughput Screen 2005; 8:327-39. (Pubitemid 40694869)
61. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin- converting enzyme 2 protects from severe acute lung failure. Nature 2005; 436:112-6. (Pubitemid 40966195)
62. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Med 2005; 11:875-9. (Pubitemid 41161120)
63. Ferrario CM. Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology. Curr Hyperten Rep 2003; 5:129-34.
64. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003; 100:8258-63.
65. Zhang H, Wada J, Hida K, Tsuchiyama Y, Hiragushi K, Shikata K, et al. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem 2001; 276:17132-9.
66. Zhang H, Wada J, Kanwar YS, Tsuchiyama Y, Hiragushi K, Hida K, et al. Screening for genes upregulated in 5/6 nephrectomized mouse kidney. Kidney Intl 1999; 56:549-58. (Pubitemid 29353153)
67. Akpinar P, Kuwajima S, Krutzfeldt J, Stoffel M. Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation. Cell Metab 2005; 2:385-97.
68. Fukui K, Yang Q, Cao Y, Takahashi N, Hatakeyama H, Wang H, et al. The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metab 2005; 2:373-84.
69. Yasuhara A, Wada J, Malakauskas SM, Zhang Y, Eguchi J, Nakatsuka A, et al. Collectrin is involved in the development of salt-sensitive hypertension by facilitating the membrane trafficking of apical membrane proteins via interaction with soluble N-ethylmaleiamide-sensitive factor attachment protein receptor complex. Circulation 2008; 118:2146-55.
70. Zhang Y, Wada J, Yasuhara A, Iseda I, Eguchi J, Fukui K, et al. The role for HNF-1beta-targeted collectrin in maintenance of primary cilia and cell polarity in collecting duct cells. PloS one 2007; 2:414.
71. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59:251-87. (Pubitemid 47481436)
72. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86:747-803. (Pubitemid 44033382)
73. Leung PS. The peptide hormone angiotensin II: its new functions in tissues and organs. Curr Protein Pept Sci 2004; 5:267-73.
74. Warner FJ, Lubel JS, McCaughan GW, Angus PW. Liver fibrosis: a balance of ACEs? Clin Sci (Lond) 2007; 113:109-18.
75. Metzger R, Bohle RM, Pauls K, Eichner G, Alhenc- Gelas F, Danilov SM, et al. Angiotensin-converting enzyme in non-neoplastic kidney diseases. Kidney Intl 1999; 56:1442-54. (Pubitemid 29451251)
76. Ingert C, Grima M, Coquard C, Barthelmebs M, Imbs JL. Contribution of angiotensin II internalization to intrarenal angiotensin II levels in rats. Am J Physiol Renal Physiol 2002; 283:1003-10.
77. Pohl M, Kaminski H, Castrop H, Bader M, Himmerkus N, Bleich M, et al. Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem 285:41935-46.
78. - reabsorption. The American journal of physiology 1996; 271:977-84.
79. - cotransporter by angiotensin II in rabbit renal cortex. Am J Physiol 1993; 265:195-203.
80. + ATPase in rat proximal straight tubules. J Am Soc Nephrol 1991; 1:1146-52.
81. Liu FY, Cogan MG. Angiotensin II stimulation of hydrogen ion secretion in the rat early proximal tubule. Modes of action, mechanism and kinetics. J Clin Invest 1988; 82:601-7.
82. Mitchell KD, Braam B, Navar LG. Hypertensinogenic mechanisms mediated by renal actions of renin-angiotensin system. Hypertension 1992; 19:18-27.
83. Wang T, Giebisch G. Effects of angiotensin II on electrolyte transport in the early and late distal tubule in rat kidney. Am J Physiol 1996; 271:143-9.
84. Wong TP, Debnam ES, Leung PS. Involvement of an enterocyte renin-angiotensin system in the local control of SGLT1-dependent glucose uptake across the rat small intestinal brush border membrane. J Physiol 2007; 584:613-23. (Pubitemid 47578343)
85. Leung PS. Local RAS. Adv Exp Med Biol 2010; 690:69-87.
86. Ristic Z, Camargo SM, Romeo E, Bodoy S, Bertran J, Palacin M, et al. Neutral amino acid transport mediated by ortholog of imino acid transporter SIT1/ SLC6A20 in opossum kidney cells. Am J Physiol Renal Physiol 2006; 290:880-7.
87. Dales NA, Gould AE, Brown JA, Calderwood EF, Guan B, Minor CA, et al. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J Am Chem Soc 2002; 124:11852-3.
88. Levy LL, Ed. In: The Metabolic and Molecular Bases of Inherited Disesases. New York: McGraw-Hill 2001.
89. 0AT1, cause Hartnup disorder. Nat Genet 2004; 36:999-1002.
90. Cheon CK, Lee BH, Ko JM, Kim HJ, Yoo HW. Novel mutation in SLC6A19 causing late-onset seizures in Hartnup disorder. Pediatr Neurol 2010; 42:369-71.
91. Zheng Y, Zhou C, Huang Y, Bu D, Zhu X, Jiang W. A novel missense mutation in the SLC6A19 gene in a Chinese family with Hartnup disorder. Int J Dermatol 2009; 48:388-92.
92. Seow HF, Broer S, Broer A, Bailey CG, Potter SJ, Cavanaugh JA, et al. Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19. Nat Genet 2004; 36:1003-7. (Pubitemid 39167499)
93. -- dependent neurotransmitter transporters. Nature 2005; 437:215-23.
94. Azmanov DN, Rodgers H, Auray-Blais C, Giguere R, Bailey C, Broer S, et al. Persistence of the common Hartnup disease D173N allele in populations of European origin. Ann Hum Genet 2007; 71:755-61. (Pubitemid 47517259)
95. Sato Y, Zhang YW, Androutsellis-Theotokis A, Rudnick G. Analysis of transmembrane domain 2 of rat serotonin transporter by cysteine scanning mutagenesis. J Biol Chem 2004; 279:22926-33. (Pubitemid 38685594)
96. Dereeper A, Audic S, Claverie JM, Blanc G. BLAST-EXPLORER helps you building datasets for phylogenetic analysis. BMC Evol Biol 2010; 10:8.
97. Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, et al. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res 2008; 36:465-9.
98. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 2008; 9:40.
99. Nozaki J, Dakeishi M, Ohura T, Inoue K, Manabe M, Wada Y, et al. Homozygosity mapping to chromosome 5p15 of a gene responsible for Hartnup disorder. Biochem Biophys Res Commun 2001; 284:255-60. (Pubitemid 32917968)
100. Potter SJ, Lu A, Wilcken B, Green K, Rasko JE. Hartnup disorder: polymorphisms identified in the neutral amino acid transporter SLC1A5. J Inherit Metab Dis 2002; 25:437-48. (Pubitemid 36104379)
101. Azmanov DN, Kowalczuk S, Rodgers H, Auray-Blais C, Giguere R, Rasko JE, et al. Further evidence for allelic heterogeneity in Hartnup disorder. Hum Mutat 2008; 29:1217-21.